FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

OCP Met or Exceeded 2020 Goals: Report

[ Price : $8.95]

The FDA Office of Clinical Pharmacology 2020 annual report says it met or exceeded all of its goals for 2020 despite also being ve...

PDUFA Reauthorization Pre-market Talks

[ Price : $8.95]

FDA releases summaries from two meetings of the FDA/industry premarket subgroup involved in PDUFA 7 reauthorization discussions.

3 Ways to Speed Drug Approvals

[ Price : $8.95]

Two Certara consultants describe ways drug developers can help FDA speed the NDA and BLA approval process.

FDA Reviewers Back Janssen Covid-19 Authorization

[ Price : $8.95]

FDA reviewers support an emergency use authorization for Janssen Biotechs single intramuscular Covid-19 vaccine injection.

FDA Extends Nitrosamine Risk Assessment Timeframe

[ Price : $8.95]

FDA extends to 3/31 the timeframe for API and finished drug manufacturers to complete nitrosamine risk assessments.

Revised Medical Policy Council MAPP

[ Price : $8.95]

CDER publishes a revised Medical Policy Council MAPP.

Medical Device EUAs Likely to End in 2021: Recall Report

[ Price : $8.95]

Sedgwick Brand Protection says medical device manufacturers should be preparing for the likely revocation of emergency use authori...

GI Bleed Alert System Gets Breakthrough Status

[ Price : $8.95]

FDA grants Dascena a breakthrough device designation for its GI Bleed Risk Alert System, a cloud-based software application that u...

Info Collection on Single-use Device Labeling

[ Price : $8.95]

Federal Register notice: FDA seeks comments on an information collection entitled Prominent and Conspicuous Mark of Manufacturers ...

IVD Genetic Variant Databases Info Collection

[ Price : $8.95]

Federal Register notice: FDA sends to OMB an information collection extension entitled Use of Public Human Genetic Variant Databas...